Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Annovis Bio, Inc. (ANVS)

Pharmaceutical Preparations

https://www.annovisbio.com

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.

1055 WESTLAKES DRIVE, SUITE 300
BERWYN, PA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

01/29/2020

Market Cap

95,739,755

Shares Outstanding

10,260,000

Weighted SO

10,262,273

Total Employees

N/A

Upcoming Earnings

08/20/2024

Similar Tickers

SAVA --.--%

AXSM --.--%

RVPH --.--%

MCRB --.--%

AVXL --.--%

IOVA --.--%

NVAX --.--%

ANIX --.--%

TFFP --.--%

Beta

1.7400

Last Div

0.0000

Range

4.53-22.49

Chg

-0.2800

Avg Vol

1788590

Mkt Cap

95739755

Exch

NYSE

Country

US

Phone

610 727 3913

DCF Diff

7.9722

DCF

0.6378

Div Yield

0.0000

P/S

0.0000

EV Multiple

0.7722

P/FV

-0.0553

Div Yield %

0.0000

P/E

-0.0192

PEG

0.0002

Payout

0.0000

Current Ratio

0.9853

Quick Ratio

0.9853

Cash Ratio

0.9853

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0000

ROA

-1.0024

ROE

11.5270

ROCE

-5.1090

NI/EBT

1.0000

EBT/EBIT

1.0010

EBIT/Rev

0.0000

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

256.4270

CF/Debt

0.0000

Equity Multi

-2.8822

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-2.0189

FCF/Share

-2.0189

Cash/Share

353.5419

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

-0.0553

P/B

-0.0553

P/S

0.0000

P/E

-0.0192

P/FCF

-4.1937

P/OCF

-4.2448

P/CF

-4.2448

PEG

0.0002

P/S

0.0000

EV Multiple

0.7722

P/FV

-0.0553

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Feb 01, 01:14 Annovis Bio, Inc. Announces Proposed Public Offering Benzinga Jul 03, 03:38 TSLA, PARA, ANVS, LLY, AMZN: Top 5 Trending Stocks Today - Annovis Bio (NYSE:ANVS), Amazon.com (NASDAQ ... - Benzinga GlobeNewswire Inc. Dec 11, 13:00 Annovis Bio to Participate in the 139th Yale CEO Summit GlobeNewswire Inc. Dec 05, 07:30 Annovis Bio Announces Last Patient Last Visit in the Phase III Study of Buntanetap in Parkinson’s Disease GlobeNewswire Inc. Nov 27, 07:30 Annovis Bio Announces Full Enrollment of Its Phase II/III Alzheimer’s Disease Trial, Exceeding Original Projections

Revenue Product Segmentation